The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, precision-led process, thanks to antenatal genomics.

Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...

Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in as little as 2 hours. The test, called ROBIN, uses PromethION nanopore sequencing to ...

Global Market OverviewThe Global Non-Invasive Prenatal Testing (NIPT) Market is projected to expand at a CAGR of 16% by 2029, ...

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...